Delivery Order SPE2DH25D0001-SPE2D426F0439
- Not listed
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a $2,799.00 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 22, 2025. The contract covers the delivery of EG7+ cartridges, which are consumable diagnostic products for point-of-care testing systems. This delivery order, issued with no set-aside designation, will be performed at Abbott's...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $10,590.00 on September 23, 2025, by the Defense Medical Supply Chain. The contract is for EG7+ cartridges and carries a fixed-price structure with economic price adjustment provisions. The award utilizes full and open competition with no set-aside designation. Performance will take place in North Chicago, Illinois, with an ultimate completion date of September 25, 2025. This delivery...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order on September 18, 2025, with a ceiling value of $1,166.25 for an EG7+ Cartridge under a fixed-price contract with economic price adjustment provisions. The delivery order has an ultimate completion date of September 22, 2025, and will be performed at Abbott's North Chicago, Illinois location. This award represents a child contract under a larger vehicle structure and was procured through full and...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order on June 30, 2025, valued at $6,877.00 for EG7+ cartridge supplies. The contract is fixed price with economic price adjustment provisions and will be performed in North Chicago, Illinois, with an ultimate completion date of July 2, 2025. This delivery order was awarded without a set-aside designation, indicating full and open competition. The funding agency is the Medical Supply Chain, a...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,166.25 on September 23, 2025, by the Medical Supply Chain, a defense-focused federal agency. The contract covers the supply of EG7+ Cartridge products and utilizes fixed price pricing with economic price adjustment provisions. The work will be performed in North Chicago, Illinois, where Abbott maintains its primary headquarters. This delivery order was awarded without any set-aside...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $3,472.50 by the Department of Defense's Medical Supply Chain on September 5, 2025, with completion expected by September 9, 2025. The contract, designated as 4569345436 and classified as a fixed-price delivery order with economic price adjustment provisions, calls for the supply of CG8+ cartridges to support federal healthcare operations. The work will be performed at Abbott's facility in...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $3,472.50 by the Medical Supply Chain division of the Department of Defense on August 29, 2025, with an ultimate completion date of September 3, 2025. The contract, designated as 4569273740 for a CG8+ Cartridge, utilizes fixed-price pricing with economic price adjustment terms and will be performed in North Chicago, Illinois. This delivery order represents a task order call against a...
- Abbott Laboratories Inc., through its Abbott Point of Care division, has been awarded a delivery order valued at $2,647.50 for PTPLUS cartridge supplies by the Defense Logistics Agency Medical Supply Chain on October 21, 2025, with an ultimate completion date of October 23, 2025. The contract utilizes a fixed-price structure with economic price adjustment provisions and carries no small business set-aside designation. The place of performance is North Chicago, Illinois, where Abbott maintains...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,736.25 by the Defense-affiliated Medical Supply Chain agency on August 25, 2025. The contract, which does not include a set-aside designation, covers the supply of CG8+ cartridges and is classified as a fixed-price delivery order with economic price adjustment provisions. Performance will be completed by August 27, 2025, at Abbott's North Chicago, Illinois facility. This delivery...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,736.25 by the Defense Medical Supply Chain on October 14, 2025, for CG8+ cartridges. The contract is structured as a fixed-price agreement with economic price adjustment provisions and does not utilize any set-aside designation, indicating full and open competition. Performance is scheduled for completion by October 16, 2025, at Abbott's facility in North Chicago, Illinois. This...
- SPE2DH25D0001Indefinite Delivery Contract
- SPE2DH25D0001-SPE2D426F0439Delivery Order
Abbott Laboratories Inc.'s Abbott Point of Care division has been awarded a delivery order valued at $1,481.25 by the Defense Logistics Agency Medical Supply Chain for the procurement of EG7+ cartridges. The contract, issued on October 23, 2025, with an ultimate completion date of October 27, 2025, utilizes a fixed-price pricing structure with economic price adjustment provisions and requires performance at Abbott's North Chicago, Illinois facility. This delivery order represents no set-aside designation and was competitively awarded through full and open competition. This delivery order is executed under Abbott's existing indefinite delivery vehicle portfolio with the Defense Logistics Agency Medical Supply Chain, through which the company supplies consumable diagnostic products including i-STAT cartridges and specialized testing supplies to federal healthcare agencies. Abbott's extensive relationship with the Defense Logistics Agency and the Department of Veterans Affairs across multiple Integrated Service Networks positions the company as a primary federal supplier of point-of-care testing devices and diagnostic consumables. The EG7+ cartridge delivery supports the agency's critical medical supply procurement needs for advanced diagnostic testing capabilities across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/23/25 |